OTC Pharmaceuticals - Hong Kong

  • Hong Kong
  • Revenue in the OTC Pharmaceuticals market amounts to €1,148.00m in 2024. The market is expected to grow annually by 6.24% (CAGR 2024-2029).
  • The market's largest segment is the segment Cold & Cough Remedies with a market volume of €296.20m in 2024.
  • In global comparison, most revenue is generated in the United States (€38,250m in 2024).
  • In relation to total population figures, per person revenues of €153.10 are generated in 2024.
  • In the OTC Pharmaceuticals market, 4.6% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Comparación de regiones

Analyst Opinion

The OTC Pharmaceuticals market in Hong Kong has been experiencing steady growth in recent years.

Customer preferences:
Consumers in Hong Kong have shown a growing preference for over-the-counter (OTC) medications due to their convenience and accessibility. OTC medications are readily available in pharmacies and retail stores without the need for a prescription, allowing consumers to easily self-diagnose and treat common ailments. This convenience factor has led to an increase in the demand for OTC pharmaceuticals in Hong Kong.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Hong Kong is the growing demand for vitamins and dietary supplements. With an increasing emphasis on health and wellness, consumers in Hong Kong are seeking ways to supplement their diets and improve their overall well-being. Vitamins and dietary supplements offer a convenient solution, and their popularity has been on the rise in recent years. Another trend in the market is the growing demand for pain relief medications. Hong Kong has a fast-paced lifestyle, and many individuals experience stress and fatigue, leading to common ailments such as headaches and muscle pain. OTC pain relief medications provide a quick and accessible solution for these issues, driving their demand in the market.

Local special circumstances:
Hong Kong has a highly developed healthcare system, with a strong emphasis on self-care and self-medication. The government has implemented policies to promote self-care and reduce the burden on public healthcare facilities. This has created a favorable environment for the growth of the OTC Pharmaceuticals market in Hong Kong. In addition, Hong Kong has a large aging population, which has contributed to the demand for OTC medications. As individuals age, they are more likely to experience chronic conditions and require ongoing medication. OTC pharmaceuticals provide a cost-effective option for managing these conditions, leading to increased demand in the market.

Underlying macroeconomic factors:
The strong economy in Hong Kong has contributed to the growth of the OTC Pharmaceuticals market. With a high disposable income and a strong consumer market, individuals in Hong Kong are willing to spend on healthcare products, including OTC medications. Furthermore, the increasing focus on preventive healthcare and wellness has also played a role in the growth of the market. Individuals are becoming more proactive in managing their health, and OTC pharmaceuticals offer a convenient and affordable way to do so. In conclusion, the OTC Pharmaceuticals market in Hong Kong is experiencing steady growth due to customer preferences for convenience and accessibility, as well as the local special circumstances of a strong emphasis on self-care and an aging population. The underlying macroeconomic factors, such as a strong economy and increasing focus on preventive healthcare, have also contributed to the growth of the market.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor


¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)